As per the study the Medicinal Mushroom Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Medicinal Mushroom Market Overview:
Global Medicinal Mushroom Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Medicinal Mushroom involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Medicinal Mushroom Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Medicinal Mushroom market in 2020.
Global Medicinal Mushroom Market Segmentation
By Type, Medicinal Mushroom market has been segmented into:
Shiitake
Cordyceps
Turkey Tail
Reishi
Maitake
Chaga
By Application, Medicinal Mushroom market has been segmented into:
Food And Beverage Industry
And Pharmaceutical Industry
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Medicinal Mushroom market are:
FreshCap Mushrooms LTD. (Canada)
Banken Champignons B.V. (Netherlands)
Far West Fungi (US)
Swadeshi Mushroom (India)
DXN (Malaysia)
Nikkei Marketing Limited (Canada)
Chaga Mountain
Inc (US)
Asia Pacific Farm Enterprises (Canada)
NC Exotic Mushrooms (Netherlands)
Bonduelle SA (France)
Nammex (Canada)
Naturalin (China)
Real Mushrooms (Canada)
Mitoku (Japan)
Hirano Mushroom LLC (Serbia)
Gourmet Mushrooms Inc. (US)
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Base Year
1.6 Scope of The Study
1.7 Market Segmentation
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Report Description
3.2 Market Overview: Market Definition and Scope
3.3 Porter's Five Forces Analysis
3.3.1 Bargaining Power of Supplier
3.3.2 Threat of New Entrants
3.3.3 Threat of Substitutes
3.3.4 Competitive Rivalry
3.3.5 Bargaining Power Among Buyers
3.4 Industry Value Chain Analysis
3.5 Market Dynamics
3.5.1 Drivers
3.5.2 Restraints
3.5.3 Opportunities
3.5.4 Challenges
3.6 Pestle Analysis
3.7 Analysis of the Impact of Covid-19
Chapter 4: Medicinal Mushroom Market by Type
4.1 Medicinal Mushroom Market Overview By Type (2016-2027)
4.2 Shiitake
4.2.1 Market Overview
4.2.2 Key Market Trends, Growth Factors and Opportunities
4.2.3 Historic and Forecasted Market Size (2016-2027)
4.2.4 Historic and Forecasted Market Size By Region (2016-2027)
4.3 Cordyceps
4.3.1 Market Overview
4.3.2 Key Market Trends, Growth Factors and Opportunities
4.3.3 Historic and Forecasted Market Size (2016-2027)
4.3.4 Historic and Forecasted Market Size By Region (2016-2027)
4.4 Turkey Tail
4.4.1 Market Overview
4.4.2 Key Market Trends, Growth Factors and Opportunities
4.4.3 Historic and Forecasted Market Size (2016-2027)
4.4.4 Historic and Forecasted Market Size By Region (2016-2027)
4.5 Reishi
4.5.1 Market Overview
4.5.2 Key Market Trends, Growth Factors and Opportunities
4.5.3 Historic and Forecasted Market Size (2016-2027)
4.5.4 Historic and Forecasted Market Size By Region (2016-2027)
4.6 Maitake
4.6.1 Market Overview
4.6.2 Key Market Trends, Growth Factors and Opportunities
4.6.3 Historic and Forecasted Market Size (2016-2027)
4.6.4 Historic and Forecasted Market Size By Region (2016-2027)
4.7 Chaga
4.7.1 Market Overview
4.7.2 Key Market Trends, Growth Factors and Opportunities
4.7.3 Historic and Forecasted Market Size (2016-2027)
4.7.4 Historic and Forecasted Market Size By Region (2016-2027)
Chapter 5: Medicinal Mushroom Market by Form
5.1 Medicinal Mushroom Market Overview By Form (2016-2027)
5.2 Whole
5.2.1 Market Overview
5.2.2 Key Market Trends, Growth Factors and Opportunities
5.2.3 Historic and Forecasted Market Size (2016-2027)
5.2.4 Historic and Forecasted Market Size By Region (2016-2027)
5.3 Dried
5.3.1 Market Overview
5.3.2 Key Market Trends, Growth Factors and Opportunities
5.3.3 Historic and Forecasted Market Size (2016-2027)
5.3.4 Historic and Forecasted Market Size By Region (2016-2027)
5.4 Liquid
5.4.1 Market Overview
5.4.2 Key Market Trends, Growth Factors and Opportunities
5.4.3 Historic and Forecasted Market Size (2016-2027)
5.4.4 Historic and Forecasted Market Size By Region (2016-2027)
5.5 Slice
5.5.1 Market Overview
5.5.2 Key Market Trends, Growth Factors and Opportunities
5.5.3 Historic and Forecasted Market Size (2016-2027)
5.5.4 Historic and Forecasted Market Size By Region (2016-2027)
5.6 And Capsules
5.6.1 Market Overview
5.6.2 Key Market Trends, Growth Factors and Opportunities
5.6.3 Historic and Forecasted Market Size (2016-2027)
5.6.4 Historic and Forecasted Market Size By Region (2016-2027)
Chapter 6: Medicinal Mushroom Market by End User
6.1 Medicinal Mushroom Market Overview By End User (2016-2027)
6.2 Food And Beverage Industry
6.2.1 Market Overview
6.2.2 Key Market Trends, Growth Factors and Opportunities
6.2.3 Historic and Forecasted Market Size (2016-2027)
6.2.4 Historic and Forecasted Market Size By Region (2016-2027)
6.3 And Pharmaceutical Industry
6.3.1 Market Overview
6.3.2 Key Market Trends, Growth Factors and Opportunities
6.3.3 Historic and Forecasted Market Size (2016-2027)
6.3.4 Historic and Forecasted Market Size By Region (2016-2027)
Chapter 7: Medicinal Mushroom Market by Distribution Channel
7.1 Medicinal Mushroom Market Overview By Distribution Channel (2016-2027)
7.2 Supermarkets And Hypermarkets
7.2.1 Market Overview
7.2.2 Key Market Trends, Growth Factors and Opportunities
7.2.3 Historic and Forecasted Market Size (2016-2027)
7.2.4 Historic and Forecasted Market Size By Region (2016-2027)
7.3 Convenience Stores
7.3.1 Market Overview
7.3.2 Key Market Trends, Growth Factors and Opportunities
7.3.3 Historic and Forecasted Market Size (2016-2027)
7.3.4 Historic and Forecasted Market Size By Region (2016-2027)
7.4 And E-Commerce
7.4.1 Market Overview
7.4.2 Key Market Trends, Growth Factors and Opportunities
7.4.3 Historic and Forecasted Market Size (2016-2027)
7.4.4 Historic and Forecasted Market Size By Region (2016-2027)
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competition Analysis
8.1.2 Strategies By Top Leading Players
8.1.3 Mergers and Acquisitions
8.1.4 Top Winning Strategies
8.2 FRESHCAP MUSHROOMS LTD. (CANADA)
8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Business Performance
8.2.4 Product Portfolio
8.2.5 Key Strategic Moves and Recent Developments
8.3 BANKEN CHAMPIGNONS B.V. (NETHERLANDS)
8.3.1 Company Overview
8.3.2 Company Snapshot
8.3.3 Business Performance
8.3.4 Product Portfolio
8.3.5 Key Strategic Moves and Recent Developments
8.4 FAR WEST FUNGI (US)
8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Business Performance
8.4.4 Product Portfolio
8.4.5 Key Strategic Moves and Recent Developments
8.5 SWADESHI MUSHROOM (INDIA)
8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Business Performance
8.5.4 Product Portfolio
8.5.5 Key Strategic Moves and Recent Developments
8.6 DXN (MALAYSIA)
8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Business Performance
8.6.4 Product Portfolio
8.6.5 Key Strategic Moves and Recent Developments
8.7 NIKKEI MARKETING LIMITED (CANADA)
8.7.1 Company Overview
8.7.2 Company Snapshot
8.7.3 Business Performance
8.7.4 Product Portfolio
8.7.5 Key Strategic Moves and Recent Developments
8.8 CHAGA MOUNTAIN
8.8.1 Company Overview
8.8.2 Company Snapshot
8.8.3 Business Performance
8.8.4 Product Portfolio
8.8.5 Key Strategic Moves and Recent Developments
8.9 INC (US)
8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Business Performance
8.9.4 Product Portfolio
8.9.5 Key Strategic Moves and Recent Developments
8.10 ASIA PACIFIC FARM ENTERPRISES (CANADA)
8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Business Performance
8.10.4 Product Portfolio
8.10.5 Key Strategic Moves and Recent Developments
8.11 NC EXOTIC MUSHROOMS (NETHERLANDS)
8.11.1 Company Overview
8.11.2 Company Snapshot
8.11.3 Business Performance
8.11.4 Product Portfolio
8.11.5 Key Strategic Moves and Recent Developments
8.12 BONDUELLE SA (FRANCE)
8.12.1 Company Overview
8.12.2 Company Snapshot
8.12.3 Business Performance
8.12.4 Product Portfolio
8.12.5 Key Strategic Moves and Recent Developments
8.13 NAMMEX (CANADA)
8.13.1 Company Overview
8.13.2 Company Snapshot
8.13.3 Business Performance
8.13.4 Product Portfolio
8.13.5 Key Strategic Moves and Recent Developments
8.14 NATURALIN (CHINA)
8.14.1 Company Overview
8.14.2 Company Snapshot
8.14.3 Business Performance
8.14.4 Product Portfolio
8.14.5 Key Strategic Moves and Recent Developments
8.15 REAL MUSHROOMS (CANADA)
8.15.1 Company Overview
8.15.2 Company Snapshot
8.15.3 Business Performance
8.15.4 Product Portfolio
8.15.5 Key Strategic Moves and Recent Developments
8.16 MITOKU (JAPAN)
8.16.1 Company Overview
8.16.2 Company Snapshot
8.16.3 Business Performance
8.16.4 Product Portfolio
8.16.5 Key Strategic Moves and Recent Developments
8.17 HIRANO MUSHROOM LLC (SERBIA)
8.17.1 Company Overview
8.17.2 Company Snapshot
8.17.3 Business Performance
8.17.4 Product Portfolio
8.17.5 Key Strategic Moves and Recent Developments
8.18 GOURMET MUSHROOMS INC. (US)
8.18.1 Company Overview
8.18.2 Company Snapshot
8.18.3 Business Performance
8.18.4 Product Portfolio
8.18.5 Key Strategic Moves and Recent Developments
Chapter 9: Global Medicinal Mushroom Market By Region
9.1 Overview
9.2 North America
9.2.1 Market Overview
9.2.2 Key Market Trends, Growth Factors and Opportunities
9.2.2 Historic and Forecast Market Size by Type
9.2.3 Historic and Forecast Market Size by Form
9.2.4 Historic and Forecast Market Size by End User
9.2.5 Historic and Forecast Market Size by Distribution Channel
9.2.6 Historic and Forecast Market Size by Country
9.3 Europe
9.3.1 Market Overview
9.3.2 Key Market Trends, Growth Factors and Opportunities
9.3.2 Historic and Forecast Market Size by Type
9.3.3 Historic and Forecast Market Size by Form
9.3.4 Historic and Forecast Market Size by End User
9.3.5 Historic and Forecast Market Size by Distribution Channel
9.3.6 Historic and Forecast Market Size by Country
9.4 Asia Pacific
9.4.1 Market Overview
9.4.2 Key Market Trends, Growth Factors and Opportunities
9.4.2 Historic and Forecast Market Size by Type
9.4.3 Historic and Forecast Market Size by Form
9.4.4 Historic and Forecast Market Size by End User
9.4.5 Historic and Forecast Market Size by Distribution Channel
9.4.6 Historic and Forecast Market Size by Country
9.5 Middle East & Africa
9.5.1 Market Overview
9.5.2 Key Market Trends, Growth Factors and Opportunities
9.5.2 Historic and Forecast Market Size by Type
9.5.3 Historic and Forecast Market Size by Form
9.5.4 Historic and Forecast Market Size by End User
9.5.5 Historic and Forecast Market Size by Distribution Channel
9.5.6 Historic and Forecast Market Size by Country
9.6 South America
9.6.1 Market Overview
9.6.2 Key Market Trends, Growth Factors and Opportunities
9.6.2 Historic and Forecast Market Size by Type
9.6.3 Historic and Forecast Market Size by Form
9.6.4 Historic and Forecast Market Size by End User
9.6.5 Historic and Forecast Market Size by Distribution Channel
9.6.6 Historic and Forecast Market Size by Country
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. MEDICINAL MUSHROOM MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. MEDICINAL MUSHROOM MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. MEDICINAL MUSHROOM MARKET COMPETITIVE RIVALRY
TABLE 005. MEDICINAL MUSHROOM MARKET THREAT OF NEW ENTRANTS
TABLE 006. MEDICINAL MUSHROOM MARKET THREAT OF SUBSTITUTES
TABLE 007. MEDICINAL MUSHROOM MARKET BY TYPE
TABLE 008. SHIITAKE MARKET OVERVIEW (2016-2027)
TABLE 009. CORDYCEPS MARKET OVERVIEW (2016-2027)
TABLE 010. TURKEY TAIL MARKET OVERVIEW (2016-2027)
TABLE 011. REISHI MARKET OVERVIEW (2016-2027)
TABLE 012. MAITAKE MARKET OVERVIEW (2016-2027)
TABLE 013. CHAGA MARKET OVERVIEW (2016-2027)
TABLE 014. MEDICINAL MUSHROOM MARKET BY FORM
TABLE 015. WHOLE MARKET OVERVIEW (2016-2027)
TABLE 016. DRIED MARKET OVERVIEW (2016-2027)
TABLE 017. LIQUID MARKET OVERVIEW (2016-2027)
TABLE 018. SLICE MARKET OVERVIEW (2016-2027)
TABLE 019. AND CAPSULES MARKET OVERVIEW (2016-2027)
TABLE 020. MEDICINAL MUSHROOM MARKET BY END USER
TABLE 021. FOOD AND BEVERAGE INDUSTRY MARKET OVERVIEW (2016-2027)
TABLE 022. AND PHARMACEUTICAL INDUSTRY MARKET OVERVIEW (2016-2027)
TABLE 023. MEDICINAL MUSHROOM MARKET BY DISTRIBUTION CHANNEL
TABLE 024. SUPERMARKETS AND HYPERMARKETS MARKET OVERVIEW (2016-2027)
TABLE 025. CONVENIENCE STORES MARKET OVERVIEW (2016-2027)
TABLE 026. AND E-COMMERCE MARKET OVERVIEW (2016-2027)
TABLE 027. NORTH AMERICA MEDICINAL MUSHROOM MARKET, BY TYPE (2016-2027)
TABLE 028. NORTH AMERICA MEDICINAL MUSHROOM MARKET, BY FORM (2016-2027)
TABLE 029. NORTH AMERICA MEDICINAL MUSHROOM MARKET, BY END USER (2016-2027)
TABLE 030. NORTH AMERICA MEDICINAL MUSHROOM MARKET, BY DISTRIBUTION CHANNEL (2016-2027)
TABLE 031. NORTH AMERICA MEDICINAL MUSHROOM MARKET, BY COUNTRY (2016-2027)
TABLE 032. EUROPE MEDICINAL MUSHROOM MARKET, BY TYPE (2016-2027)
TABLE 033. EUROPE MEDICINAL MUSHROOM MARKET, BY FORM (2016-2027)
TABLE 034. EUROPE MEDICINAL MUSHROOM MARKET, BY END USER (2016-2027)
TABLE 035. EUROPE MEDICINAL MUSHROOM MARKET, BY DISTRIBUTION CHANNEL (2016-2027)
TABLE 036. EUROPE MEDICINAL MUSHROOM MARKET, BY COUNTRY (2016-2027)
TABLE 037. ASIA PACIFIC MEDICINAL MUSHROOM MARKET, BY TYPE (2016-2027)
TABLE 038. ASIA PACIFIC MEDICINAL MUSHROOM MARKET, BY FORM (2016-2027)
TABLE 039. ASIA PACIFIC MEDICINAL MUSHROOM MARKET, BY END USER (2016-2027)
TABLE 040. ASIA PACIFIC MEDICINAL MUSHROOM MARKET, BY DISTRIBUTION CHANNEL (2016-2027)
TABLE 041. ASIA PACIFIC MEDICINAL MUSHROOM MARKET, BY COUNTRY (2016-2027)
TABLE 042. MIDDLE EAST & AFRICA MEDICINAL MUSHROOM MARKET, BY TYPE (2016-2027)
TABLE 043. MIDDLE EAST & AFRICA MEDICINAL MUSHROOM MARKET, BY FORM (2016-2027)
TABLE 044. MIDDLE EAST & AFRICA MEDICINAL MUSHROOM MARKET, BY END USER (2016-2027)
TABLE 045. MIDDLE EAST & AFRICA MEDICINAL MUSHROOM MARKET, BY DISTRIBUTION CHANNEL (2016-2027)
TABLE 046. MIDDLE EAST & AFRICA MEDICINAL MUSHROOM MARKET, BY COUNTRY (2016-2027)
TABLE 047. SOUTH AMERICA MEDICINAL MUSHROOM MARKET, BY TYPE (2016-2027)
TABLE 048. SOUTH AMERICA MEDICINAL MUSHROOM MARKET, BY FORM (2016-2027)
TABLE 049. SOUTH AMERICA MEDICINAL MUSHROOM MARKET, BY END USER (2016-2027)
TABLE 050. SOUTH AMERICA MEDICINAL MUSHROOM MARKET, BY DISTRIBUTION CHANNEL (2016-2027)
TABLE 051. SOUTH AMERICA MEDICINAL MUSHROOM MARKET, BY COUNTRY (2016-2027)
TABLE 052. FRESHCAP MUSHROOMS LTD. (CANADA): SNAPSHOT
TABLE 053. FRESHCAP MUSHROOMS LTD. (CANADA): BUSINESS PERFORMANCE
TABLE 054. FRESHCAP MUSHROOMS LTD. (CANADA): PRODUCT PORTFOLIO
TABLE 055. FRESHCAP MUSHROOMS LTD. (CANADA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. BANKEN CHAMPIGNONS B.V. (NETHERLANDS): SNAPSHOT
TABLE 056. BANKEN CHAMPIGNONS B.V. (NETHERLANDS): BUSINESS PERFORMANCE
TABLE 057. BANKEN CHAMPIGNONS B.V. (NETHERLANDS): PRODUCT PORTFOLIO
TABLE 058. BANKEN CHAMPIGNONS B.V. (NETHERLANDS): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. FAR WEST FUNGI (US): SNAPSHOT
TABLE 059. FAR WEST FUNGI (US): BUSINESS PERFORMANCE
TABLE 060. FAR WEST FUNGI (US): PRODUCT PORTFOLIO
TABLE 061. FAR WEST FUNGI (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. SWADESHI MUSHROOM (INDIA): SNAPSHOT
TABLE 062. SWADESHI MUSHROOM (INDIA): BUSINESS PERFORMANCE
TABLE 063. SWADESHI MUSHROOM (INDIA): PRODUCT PORTFOLIO
TABLE 064. SWADESHI MUSHROOM (INDIA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. DXN (MALAYSIA): SNAPSHOT
TABLE 065. DXN (MALAYSIA): BUSINESS PERFORMANCE
TABLE 066. DXN (MALAYSIA): PRODUCT PORTFOLIO
TABLE 067. DXN (MALAYSIA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. NIKKEI MARKETING LIMITED (CANADA): SNAPSHOT
TABLE 068. NIKKEI MARKETING LIMITED (CANADA): BUSINESS PERFORMANCE
TABLE 069. NIKKEI MARKETING LIMITED (CANADA): PRODUCT PORTFOLIO
TABLE 070. NIKKEI MARKETING LIMITED (CANADA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. CHAGA MOUNTAIN: SNAPSHOT
TABLE 071. CHAGA MOUNTAIN: BUSINESS PERFORMANCE
TABLE 072. CHAGA MOUNTAIN: PRODUCT PORTFOLIO
TABLE 073. CHAGA MOUNTAIN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. INC (US): SNAPSHOT
TABLE 074. INC (US): BUSINESS PERFORMANCE
TABLE 075. INC (US): PRODUCT PORTFOLIO
TABLE 076. INC (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. ASIA PACIFIC FARM ENTERPRISES (CANADA): SNAPSHOT
TABLE 077. ASIA PACIFIC FARM ENTERPRISES (CANADA): BUSINESS PERFORMANCE
TABLE 078. ASIA PACIFIC FARM ENTERPRISES (CANADA): PRODUCT PORTFOLIO
TABLE 079. ASIA PACIFIC FARM ENTERPRISES (CANADA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. NC EXOTIC MUSHROOMS (NETHERLANDS): SNAPSHOT
TABLE 080. NC EXOTIC MUSHROOMS (NETHERLANDS): BUSINESS PERFORMANCE
TABLE 081. NC EXOTIC MUSHROOMS (NETHERLANDS): PRODUCT PORTFOLIO
TABLE 082. NC EXOTIC MUSHROOMS (NETHERLANDS): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. BONDUELLE SA (FRANCE): SNAPSHOT
TABLE 083. BONDUELLE SA (FRANCE): BUSINESS PERFORMANCE
TABLE 084. BONDUELLE SA (FRANCE): PRODUCT PORTFOLIO
TABLE 085. BONDUELLE SA (FRANCE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. NAMMEX (CANADA): SNAPSHOT
TABLE 086. NAMMEX (CANADA): BUSINESS PERFORMANCE
TABLE 087. NAMMEX (CANADA): PRODUCT PORTFOLIO
TABLE 088. NAMMEX (CANADA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 088. NATURALIN (CHINA): SNAPSHOT
TABLE 089. NATURALIN (CHINA): BUSINESS PERFORMANCE
TABLE 090. NATURALIN (CHINA): PRODUCT PORTFOLIO
TABLE 091. NATURALIN (CHINA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 091. REAL MUSHROOMS (CANADA): SNAPSHOT
TABLE 092. REAL MUSHROOMS (CANADA): BUSINESS PERFORMANCE
TABLE 093. REAL MUSHROOMS (CANADA): PRODUCT PORTFOLIO
TABLE 094. REAL MUSHROOMS (CANADA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 094. MITOKU (JAPAN): SNAPSHOT
TABLE 095. MITOKU (JAPAN): BUSINESS PERFORMANCE
TABLE 096. MITOKU (JAPAN): PRODUCT PORTFOLIO
TABLE 097. MITOKU (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 097. HIRANO MUSHROOM LLC (SERBIA): SNAPSHOT
TABLE 098. HIRANO MUSHROOM LLC (SERBIA): BUSINESS PERFORMANCE
TABLE 099. HIRANO MUSHROOM LLC (SERBIA): PRODUCT PORTFOLIO
TABLE 100. HIRANO MUSHROOM LLC (SERBIA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. GOURMET MUSHROOMS INC. (US): SNAPSHOT
TABLE 101. GOURMET MUSHROOMS INC. (US): BUSINESS PERFORMANCE
TABLE 102. GOURMET MUSHROOMS INC. (US): PRODUCT PORTFOLIO
TABLE 103. GOURMET MUSHROOMS INC. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. MEDICINAL MUSHROOM MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. MEDICINAL MUSHROOM MARKET OVERVIEW BY TYPE
FIGURE 012. SHIITAKE MARKET OVERVIEW (2016-2027)
FIGURE 013. CORDYCEPS MARKET OVERVIEW (2016-2027)
FIGURE 014. TURKEY TAIL MARKET OVERVIEW (2016-2027)
FIGURE 015. REISHI MARKET OVERVIEW (2016-2027)
FIGURE 016. MAITAKE MARKET OVERVIEW (2016-2027)
FIGURE 017. CHAGA MARKET OVERVIEW (2016-2027)
FIGURE 018. MEDICINAL MUSHROOM MARKET OVERVIEW BY FORM
FIGURE 019. WHOLE MARKET OVERVIEW (2016-2027)
FIGURE 020. DRIED MARKET OVERVIEW (2016-2027)
FIGURE 021. LIQUID MARKET OVERVIEW (2016-2027)
FIGURE 022. SLICE MARKET OVERVIEW (2016-2027)
FIGURE 023. AND CAPSULES MARKET OVERVIEW (2016-2027)
FIGURE 024. MEDICINAL MUSHROOM MARKET OVERVIEW BY END USER
FIGURE 025. FOOD AND BEVERAGE INDUSTRY MARKET OVERVIEW (2016-2027)
FIGURE 026. AND PHARMACEUTICAL INDUSTRY MARKET OVERVIEW (2016-2027)
FIGURE 027. MEDICINAL MUSHROOM MARKET OVERVIEW BY DISTRIBUTION CHANNEL
FIGURE 028. SUPERMARKETS AND HYPERMARKETS MARKET OVERVIEW (2016-2027)
FIGURE 029. CONVENIENCE STORES MARKET OVERVIEW (2016-2027)
FIGURE 030. AND E-COMMERCE MARKET OVERVIEW (2016-2027)
FIGURE 031. NORTH AMERICA MEDICINAL MUSHROOM MARKET OVERVIEW BY COUNTRY (2016-2027)
FIGURE 032. EUROPE MEDICINAL MUSHROOM MARKET OVERVIEW BY COUNTRY (2016-2027)
FIGURE 033. ASIA PACIFIC MEDICINAL MUSHROOM MARKET OVERVIEW BY COUNTRY (2016-2027)
FIGURE 034. MIDDLE EAST & AFRICA MEDICINAL MUSHROOM MARKET OVERVIEW BY COUNTRY (2016-2027)
FIGURE 035. SOUTH AMERICA MEDICINAL MUSHROOM MARKET OVERVIEW BY COUNTRY (2016-2027)
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|